FDA considers Kyle Diamantas as acting commissioner
Updated
Updated · Reuters · May 8
FDA considers Kyle Diamantas as acting commissioner
4 articles · Updated · Reuters · May 8
The move follows a White House-approved plan to fire Commissioner Marty Makary, with Grace Graham and Sara Brenner also under consideration for the interim role.
For the permanent post, former FDA commissioner Stephen Hahn and former acting commissioner and assistant health secretary Brett Giroir are among names being weighed, according to sources.
Diamantas currently leads the agency's food group, and the potential leadership shake-up comes as the administration prepares a broader transition at the U.S. Food and Drug Administration.
Can a new FDA chief fix internal chaos while also speeding up drug approvals, or must one be sacrificed?
Will the FDA's ambitious food safety agenda survive the agency's leadership crisis and deliver its promises?